Top July 22, 2026 at 8:18 AM

Another iPS product approved for public insurance coverage in Japan

Japan Times

It is the second case of insurance coverage approval in the nation for an induced pluripotent stem cell-derived regenerative medicine product.

With a triple whammy of blistering heat, yen weakness and escalating fuel costs, the nationwide day-ahead spot price sur…

The bill to revise the law was backed by the ruling coalition as well as several opposition parties.

Japan's currency is at its weakest point against the dollar in four decades and is down one-third over five years.

AI-curated news from 12 countries and 10 languages — coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play